1
|
Ramanan AV, Sage AM. Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible? J Clin Med 2022; 11:jcm11195674. [PMID: 36233546 PMCID: PMC9570877 DOI: 10.3390/jcm11195674] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2022] [Revised: 09/15/2022] [Accepted: 09/16/2022] [Indexed: 12/02/2022] Open
Abstract
Background: Treat to target (T2T) is a strategy that has been increasingly employed in the management of several chronic diseases, with demonstrated improved outcomes. The use of T2T in juvenile idiopathic arthritis (JIA), a common rheumatic disease of childhood, is still in its infancy, and the feasibility of its use in attaining drug-free clinical remission is unclear. Aims: We aim to explore the current literature of the use of T2T in JIA, and to review the potential benefits and limitations of this approach in regard to this chronic disease. Sources: A comprehensive PubMed search was conducted using relevant keywords, with full text articles in English included in the review. Content: T2T is an appealing strategy for improving outcomes of pediatric rheumatic diseases given the limited availability of therapeutics and potential cumulative effects of long-term immunosuppression. The application in a cohort of children, however, is limited by heterogeneity of disease, availability of high-quality evidence, and patient and parental preferences. Unlike adult rheumatoid arthritis, the 'window of opportunity' has not been definitively demonstrated in large scale trials, and although early studies of T2T in JIA have been favorable, the timing and means of escalation (especially with regard to biologics) need clarification. Implications: This review outlines several issues of implementing T2T in JIA, including the important extra-articular manifestations of disease and non-pharmacological management, that should be considered in future consensus guidelines.
Collapse
Affiliation(s)
- Athimalaipet V. Ramanan
- Bristol Royal Hospital for Children, Bristol BS8 1QU, UK
- Translational Health Sciences, University of Bristol, Bristol BS8 1TS, UK
| | - Anne M. Sage
- Department of Rheumatology, Perth Children’s Hospital, 15 Hospital Avenue, Nedlands, WA 6009, Australia
- Correspondence:
| |
Collapse
|
2
|
Alunno A, Rivellese F, Lauper K, Aletaha D, Buch MH, Gossec L, Mandl P, Machado PM, Ospelt C, Molto A, Ramiro S, Nikiphorou E, Sepriano A. EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future. RMD Open 2022; 7:rmdopen-2021-001962. [PMID: 34969822 PMCID: PMC8718468 DOI: 10.1136/rmdopen-2021-001962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Accepted: 11/09/2021] [Indexed: 12/03/2022] Open
Affiliation(s)
- Alessia Alunno
- Department of Life, Health and Environmental Sciences, Internal Medicine and Nephrology Unit, University of L'Aquila, L'Aquila, Italy
| | - Felice Rivellese
- Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - Kim Lauper
- Division of Rheumatology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland, Geneva, Switzerland.,Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK
| | - Daniel Aletaha
- Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria
| | - Maya H Buch
- Centre for Musculoskeletal & dermatological Sciences, Faculty of Biology, medicine & health, University of Manchester UK, Manchester, UK.,NIHR Manchester Biomedical Research Centre, Manchester, UK
| | - Laure Gossec
- INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universite, Paris, France.,AP-HP, Rheumatology department, Pitié Salpêtrière hospital, Sorbonne Université, Paris, France
| | - Peter Mandl
- Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria
| | - Pedro M Machado
- Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.,National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK
| | - Caroline Ospelt
- Department of Rheumatology, Center of Experimental Rheumatology, University Hospital of Zurich, Zurich, Switzerland
| | - Anna Molto
- Department of Rheumatology, Hôpital Cochin. Assistance Publique - Hôpitaux de Paris, Paris, France.,INSERM U1153 Epidémiologie Clinique et Biostatistiques, PRES Sorbonne Paris-Cité, Paris, France
| | - Sofia Ramiro
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.,Department of Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands
| | - Elena Nikiphorou
- Centre for Rheumatic Diseases, King's College London, London, UK.,Rheumatology Department, King's College Hospital, London, UK
| | - Alexandre Sepriano
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.,NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal
| |
Collapse
|
3
|
Mohsin Z, Asghar AA, Faiq A, Khalid I, Ul-Haque I, Rehman S, Ahmed SI, Basalat ST, Aimen A, Shafique S, Hanif A, Iqbal MW, Samad SA, Siddiqui F, Hameed I, Safri M. Prevalence of Rheumatic Diseases in a Tertiary Care Hospital of Karachi. Cureus 2018; 10:e2858. [PMID: 30148011 PMCID: PMC6107035 DOI: 10.7759/cureus.2858] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
BACKGROUND Rheumatic diseases are referred to as conditions affecting joints, muscles, ligaments, tendons, and bones. According to a report by World Health Organization, rheumatic and musculoskeletal diseases were labeled as the second most reported cause of disability around the globe. The purpose of this study was to estimate the prevalence of rheumatic diseases in a tertiary care hospital of Karachi; additionally, associations with age groups, gender and comorbidities were obtained as well. METHODS A cross-sectional study was conducted at the Orthopedic Out Patient Department (OPD) of Dr. Ruth KM Pfau Civil Hospital, Karachi over a span of three months in 2018 (February till May). All 346 patients were follow-up diagnosed cases in the age range of 11-90 years, divided into groups of adolescents, young adults, adults, and older adults. The subjects were questioned about their symptoms, duration of illness, presence of comorbidities, genetic background and the therapy they are undergoing along with compliance. Simple statistical analysis of frequency was done, whereas chi-square test was applied to study associations with gender, age groups, and comorbidities. RESULTS During the study period, a total of 2000 patients visited the orthopedic OPD, 346 of which were diagnosed cases of rheumatic diseases, yielding a prevalence of 17.3%. The mean age of rheumatic patients who partook in the study was 46.15 ± 15.49 (Range: 12 - 84). Osteoarthritis was recorded as the most prevalent condition, followed by non-specific low back pain and rheumatoid arthritis. Osteoarthritis was statistically significant in young adults, adults, and older adults, while non-specific low back pain had significant associations with gender, young adults, and adults. Diabetes was significantly associated with osteoarthritis, non-specific low back pain, shoulder pain syndrome and psoriatic arthritis, while hypertension significantly co-existed with systemic lupus erthematosus. CONCLUSION Rheumatic diseases constitute a major disease burden in almost all of the age groups, especially in young patients (18-40 years) within our setup.
Collapse
Affiliation(s)
- Zainab Mohsin
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | - Arifa A Asghar
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | - Arisha Faiq
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | - Ilma Khalid
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | - Ibtehaj Ul-Haque
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi , PAK
| | - Sameen Rehman
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | - Saffia I Ahmed
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | | | - Abeeha Aimen
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, PAK
| | - Shiza Shafique
- Dow University of Health Sciences, Civil Hospital, Karachi, PAK
| | - Ayesha Hanif
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan, Karachi, PAK
| | - Muhammad Waqas Iqbal
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan, Karachi, PAK
| | - Syed A Samad
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan, Karachi, PAK
| | - Faiza Siddiqui
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan, Karachi, PAK
| | - Ishaque Hameed
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan, Karachi, PAK
| | - Marzia Safri
- Dow Medical College, Dow University of Health Sciences (DUHS), Karachi, Pakistan, Karachi, PAK
| |
Collapse
|